Bariatric surgery: an IDF statement for obese Type 2 diabetes.
about
Interventions for treating overweight or obesity in adults: an overview of systematic reviewsNew obesity classification criteria as a tool for bariatric surgery indicationBariatric surgery and diabetes remission: Who would have thought it?Current status of bariatric surgery in Japan and effectiveness in obesity and diabetesUpdate on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association.Recent advances in bariatric/metabolic surgery: appraisal of clinical evidenceBariatric Surgery for Type 2 Diabetes Mellitus in Patients with BMI <30 kg/m2: A Systematic Review and Meta-AnalysisSurgical treatment of type 2 diabetes: the surgeon perspective.Effects of bariatric surgery on metabolic and nutritional parameters in severely obese Korean patients with type 2 diabetes: A prospective 2-year follow up.Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomesThe sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgeryFilling the treatment gap in the weight management of overweight and obese patients.Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American SocBeyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery.Metabolic bariatric surgery and type 2 diabetes mellitus: an endocrinologist's perspective.Comparison Between Banded and Nonbanded Roux-En-Y Gastric Bypass with 2-Year Follow-Up: a Preliminary Retrospective Analysis.The prevention and treatment of obesity.The importance of weight management in type 2 diabetes mellitus.Morbid obesity in women on the rise: an observational, population-based studyDynamics of type 2 diabetes mellitus laboratory remission after Roux-en-Y gastric bypass in patients with body mass index lower than 35 kg/m(2) and higher than 35 kg/m(2) in a 3-year observation period.Influence of peri-duodenal non-constrictive cuff on the body weight of rats.Correlation between postoperative weight loss and diabetes mellitus remission: a meta-analysis.The long-term effects of bariatric surgery for type 2 diabetes: systematic review and meta-analysis of randomized and non-randomized evidence.Timing of bariatric surgery in people with obesity and diabetes.The Short-Term Remission of Diabetic Nephropathy After Roux-en-Y Gastric Bypass in Chinese Patients of T2DM with ObesityLong-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg/m(2).Ileal Interposition in Rats with Experimental Type 2 Like Diabetes Improves Glycemic Control Independently of Glucose Absorption.Transculturalization of a diabetes-specific nutrition algorithm: Asian application.Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI < 35 kg/m(2)Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity.Advantages of bariatric medicine for individualized prevention and treatments: multidisciplinary approach in body culture and prevention of obesity and diabetes.Quick fix or long-term cure? Pros and cons of bariatric surgeryThe effect of laparoscopic sleeve gastrectomy on morbid obesity and obesity-related comorbidities: A cohort studyCardiovascular events after bariatric surgery in obese subjects with type 2 diabetes.Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes.FGF 19 and Bile Acids Increase Following Roux-en-Y Gastric Bypass but Not After Medical Management in Patients with Type 2 Diabetes.Use of the DISST model to estimate the HOMA and Matsuda indexes using only a basal insulin assayLong-term mortality and incidence of cardiovascular diseases and type 2 diabetes in diabetic and nondiabetic obese patients undergoing gastric banding: a controlled study.Effectiveness and safety of laparoscopic Roux-en-Y gastric bypass for the treatment of type 2 diabetes mellitus.EXTERNAL VALIDATION OF THE DIAREM SCORE AS REMISSION PREDICTOR OF DIABETES MELLITUS TYPE 2 IN OBESE PATIENTS UNDERGOING ROUX-EN-Y GASTRIC BYPASS.
P2860
Q24200908-0DD7ED83-92A3-4354-AEC3-0A896C94D4E3Q26774656-22FA8628-18EB-4FD1-AF7C-25F0B84A98BBQ26783213-5F6DF412-B92A-492A-8FB6-E310AC05EFB5Q26998089-4C18EE62-EC82-4942-8D2D-720580E9F028Q27687851-E35C763B-5740-4300-889C-26FB33CE76F9Q28083094-55F1EE0C-38C0-40B5-9B73-3DA45D92B96FQ28546462-BDF60524-26B6-4345-B961-055C86B29DA1Q30405974-6AC734CF-F995-4626-890B-4D302AF45B8CQ33622278-1153F838-8C5C-44F9-AB02-0CE9203D1489Q33746480-115FE4BA-DD7E-44D8-9362-5B454C9D6635Q33761529-EB6314EB-A41B-4F98-8A36-47405668F62FQ33873328-0F6A4302-65B4-4B2D-BD80-555C0D12F2F4Q34075016-0D0E8A96-FB59-4A98-ACED-BBF5157946C9Q34159784-08824147-0166-4147-996F-04FC1CBE7119Q34471033-F883A3C6-5D86-4141-8DBB-C544BE26FEBFQ34498601-01BF6630-E42C-4592-9FC8-44E5F5AD6396Q34521259-0D961875-F7F0-4A57-B2CF-04246F74732BQ34547464-3C2D57F1-E46B-494D-BE03-986C9B089AD4Q34645177-3A3BEC25-D104-4E4B-A54C-DB7F37275308Q34791792-D01BDEAD-4340-4E9A-BA93-C33AE324BB24Q34978564-F72428B0-7054-4285-AABD-5EFA2D1D8CAEQ35169214-208AEF91-09D5-4A8C-A8B9-8F9B26B72550Q35376124-BFE7A02E-A5EF-4C10-9E70-0A6E3FED7650Q35603731-BB378189-37A5-4DE3-872E-1FC9C5098351Q35698046-D9123463-73B2-4C5D-8BE9-C85964A32407Q35704093-3DADC0D1-69F3-412D-BAEA-4C55D6915FB2Q35818151-04300726-3019-47E5-AA8E-6B2CC63A9C51Q35828186-A9078DD7-68C0-4928-858E-B5A5ED84033EQ36031995-307F2015-C6A7-4AFB-9969-24AAF8E7F992Q36047225-D0868A8B-3749-4E0E-9B26-1A5A21EC0E55Q36117955-3DB52E11-B830-4D92-935A-0258034D7BB0Q36314717-C41B4FB6-15E5-41FD-9762-DF62A9D7CFFDQ36358681-5533E713-98BC-4E10-B10B-0CF67D1765A0Q36426708-E7FDFE5D-8CDC-44FB-B2F8-8C520DE7EAFAQ36477817-496B162B-BEC9-46CF-B530-B4B9BD79B0E9Q36573090-3B8C14F3-CC5E-440B-B374-56B3F67BD080Q36608935-6DE6BA50-996B-483D-ABE5-5DA2F5476D30Q36625446-754F5574-26A6-46DE-AB42-59EBC4F6FACDQ36639808-C1066C5F-FC16-4A16-8CE6-1CC2164977D9Q36696138-64E953E9-F12D-473E-9A95-67F2DE5A2E6B
P2860
Bariatric surgery: an IDF statement for obese Type 2 diabetes.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Bariatric surgery: an IDF statement for obese Type 2 diabetes.
@ast
Bariatric surgery: an IDF statement for obese Type 2 diabetes.
@en
type
label
Bariatric surgery: an IDF statement for obese Type 2 diabetes.
@ast
Bariatric surgery: an IDF statement for obese Type 2 diabetes.
@en
prefLabel
Bariatric surgery: an IDF statement for obese Type 2 diabetes.
@ast
Bariatric surgery: an IDF statement for obese Type 2 diabetes.
@en
P2093
P2860
P921
P1433
P1476
Bariatric surgery: an IDF statement for obese Type 2 diabetes.
@en
P2093
International Diabetes Federation Taskforce on Epidemiology and Prevention
K G Alberti
P2860
P304
P356
10.1111/J.1464-5491.2011.03306.X
P577
2011-06-01T00:00:00Z